Microscopic Polyangiitis Treatment Market
1 Study Coverage
1.1 Microscopic Polyangiitis (MPA) Treatment Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Microscopic Polyangiitis (MPA) Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size for the Year 2017-2028
1.2.2 Global Microscopic Polyangiitis (MPA) Treatment Market Size for the Year 2017-2028
1.3 Microscopic Polyangiitis (MPA) Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Microscopic Polyangiitis (MPA) Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Microscopic Polyangiitis (MPA) Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Microscopic Polyangiitis (MPA) Treatment Market Dynamics
1.4.1 Microscopic Polyangiitis (MPA) Treatment Industry Trends
1.4.2 Microscopic Polyangiitis (MPA) Treatment Market Drivers
1.4.3 Microscopic Polyangiitis (MPA) Treatment Market Challenges
1.4.4 Microscopic Polyangiitis (MPA) Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Microscopic Polyangiitis (MPA) Treatment by Type
2.1 Microscopic Polyangiitis (MPA) Treatment Market Segment by Type
2.1.1 Avacopan
2.1.2 Immune Globulin
2.1.3 Rituximab Biosimilar
2.1.4 Others
2.2 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2017-2028)
2.4 United States Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2017-2028)
3 Microscopic Polyangiitis (MPA) Treatment by Application
3.1 Microscopic Polyangiitis (MPA) Treatment Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2017-2028)
3.4 United States Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2017-2028)
4 Global Microscopic Polyangiitis (MPA) Treatment Competitor Landscape by Company
4.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Company
4.1.1 Top Global Microscopic Polyangiitis (MPA) Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue by Player (2017-2022)
4.2 Global Microscopic Polyangiitis (MPA) Treatment Concentration Ratio (CR)
4.2.1 Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Microscopic Polyangiitis (MPA) Treatment in 2021
4.2.3 Global Microscopic Polyangiitis (MPA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Microscopic Polyangiitis (MPA) Treatment Headquarters, Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Microscopic Polyangiitis (MPA) Treatment Headquarters and Area Served
4.3.2 Global Microscopic Polyangiitis (MPA) Treatment Companies Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Microscopic Polyangiitis (MPA) Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Microscopic Polyangiitis (MPA) Treatment Market Size by Company
4.5.1 Top Microscopic Polyangiitis (MPA) Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Microscopic Polyangiitis (MPA) Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Region
5.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Region (2017-2028)
5.2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Region: 2017-2022
5.2.2 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Microscopic Polyangiitis (MPA) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Microscopic Polyangiitis (MPA) Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Microscopic Polyangiitis (MPA) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Microscopic Polyangiitis (MPA) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Microscopic Polyangiitis (MPA) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Celltrion Inc
7.1.1 Celltrion Inc Company Details
7.1.2 Celltrion Inc Business Overview
7.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Introduction
7.1.4 Celltrion Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022)
7.1.5 Celltrion Inc Recent Development
7.2 ChemoCentryx Inc
7.2.1 ChemoCentryx Inc Company Details
7.2.2 ChemoCentryx Inc Business Overview
7.2.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Introduction
7.2.4 ChemoCentryx Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022)
7.2.5 ChemoCentryx Inc Recent Development
7.3 Sandoz International GmbH
7.3.1 Sandoz International GmbH Company Details
7.3.2 Sandoz International GmbH Business Overview
7.3.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Introduction
7.3.4 Sandoz International GmbH Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022)
7.3.5 Sandoz International GmbH Recent Development
7.4 Teijin Pharma Ltd
7.4.1 Teijin Pharma Ltd Company Details
7.4.2 Teijin Pharma Ltd Business Overview
7.4.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
7.4.4 Teijin Pharma Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022)
7.4.5 Teijin Pharma Ltd Recent Development
7.5 TTY Biopharm Company Ltd
7.5.1 TTY Biopharm Company Ltd Company Details
7.5.2 TTY Biopharm Company Ltd Business Overview
7.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
7.5.4 TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022)
7.5.5 TTY Biopharm Company Ltd Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Microscopic Polyangiitis (MPA) Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Microscopic Polyangiitis (MPA) Treatment Market Trends
Table 3. Microscopic Polyangiitis (MPA) Treatment Market Drivers
Table 4. Microscopic Polyangiitis (MPA) Treatment Market Challenges
Table 5. Microscopic Polyangiitis (MPA) Treatment Market Restraints
Table 6. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Microscopic Polyangiitis (MPA) Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Microscopic Polyangiitis (MPA) Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Microscopic Polyangiitis (MPA) Treatment Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Microscopic Polyangiitis (MPA) Treatment Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Microscopic Polyangiitis (MPA) Treatment Revenue Share by Player, 2017-2022
Table 13. Global Microscopic Polyangiitis (MPA) Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Microscopic Polyangiitis (MPA) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microscopic Polyangiitis (MPA) Treatment as of 2021)
Table 15. Top Players of Microscopic Polyangiitis (MPA) Treatment in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Microscopic Polyangiitis (MPA) Treatment Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Microscopic Polyangiitis (MPA) Treatment Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Microscopic Polyangiitis (MPA) Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Microscopic Polyangiitis (MPA) Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Microscopic Polyangiitis (MPA) Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Microscopic Polyangiitis (MPA) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Microscopic Polyangiitis (MPA) Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Microscopic Polyangiitis (MPA) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Microscopic Polyangiitis (MPA) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Microscopic Polyangiitis (MPA) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Celltrion Inc Company Details
Table 31. Celltrion Inc Business Overview
Table 32. Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Product
Table 33. Celltrion Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022) & (US$ Million)
Table 34. Celltrion Inc Recent Development
Table 35. ChemoCentryx Inc Company Details
Table 36. ChemoCentryx Inc Business Overview
Table 37. ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Product
Table 38. ChemoCentryx Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022) & (US$ Million)
Table 39. ChemoCentryx Inc Recent Development
Table 40. Sandoz International GmbH Company Details
Table 41. Sandoz International GmbH Business Overview
Table 42. Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Product
Table 43. Sandoz International GmbH Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022) & (US$ Million)
Table 44. Sandoz International GmbH Recent Development
Table 45. Teijin Pharma Ltd Company Details
Table 46. Teijin Pharma Ltd Business Overview
Table 47. Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Product
Table 48. Teijin Pharma Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022) & (US$ Million)
Table 49. Teijin Pharma Ltd Recent Development
Table 50. TTY Biopharm Company Ltd Company Details
Table 51. TTY Biopharm Company Ltd Business Overview
Table 52. TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Product
Table 53. TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022) & (US$ Million)
Table 54. TTY Biopharm Company Ltd Recent Development
Table 55. Research Programs/Design for This Report
Table 56. Key Data Information from Secondary Sources
Table 57. Key Data Information from Primary Sources
List of Figures
Figure 1. Microscopic Polyangiitis (MPA) Treatment Product Picture
Figure 2. Global Microscopic Polyangiitis (MPA) Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Microscopic Polyangiitis (MPA) Treatment Market Size 2017-2028 (US$ Million)
Figure 4. United States Microscopic Polyangiitis (MPA) Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Microscopic Polyangiitis (MPA) Treatment Market Size 2017-2028 (US$ Million)
Figure 6. United States Microscopic Polyangiitis (MPA) Treatment Market Share in Global 2017-2028
Figure 7. Microscopic Polyangiitis (MPA) Treatment Report Years Considered
Figure 8. Product Picture of Avacopan
Figure 9. Product Picture of Immune Globulin
Figure 10. Product Picture of Rituximab Biosimilar
Figure 11. Product Picture of Others
Figure 12. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Type in 2022 & 2028
Figure 13. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2017-2028)
Figure 15. United States Microscopic Polyangiitis (MPA) Treatment Market Share by Type in 2022 & 2028
Figure 16. United States Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2017-2028)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Others
Figure 21. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Application in 2022 & 2028
Figure 22. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2017-2028)
Figure 24. United States Microscopic Polyangiitis (MPA) Treatment Market Share by Application in 2022 & 2028
Figure 25. United States Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2017-2028)
Figure 27. North America Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.A.E Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Celltrion Inc Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022)
Figure 56. ChemoCentryx Inc Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022)
Figure 57. Sandoz International GmbH Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022)
Figure 58. Teijin Pharma Ltd Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022)
Figure 59. TTY Biopharm Company Ltd Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Industry Market Size
